Positron emission tomography assessment of effects of benzodiazepines on regional glucose metabolic rate in patients with anxiety disorder

Keyphrases

• Anxiety Disorders 100%
• Benzodiazepines 100%
• Positron Emission Tomography 100%
• Glucose Metabolic Rate 100%
• Basal Ganglia 50%
• Brain Regions 50%
• Placebo-controlled 50%
• Random Assignment 50%
• Receptor Binding 50%
• Visual Cortex 50%
• Benzodiazepine Receptor 50%
• Generalized Anxiety Disorder 50%
• Metabolic Rate 50%
• 18F-fluorodeoxyglucose (18F-FDG) 50%
• Receptor Density 50%
• Clinical Autopsy 50%
• Autopsy Study 50%
• Clorazepate 50%

Neuroscience

• Positron Emission Tomography 100%
• Anxiety Disorder 100%
• Thalamus 50%
• Basal Ganglia 50%
• Visual Cortex 50%
• Placebo 50%
• Receptor Binding 50%
• Fluorine-18 50%
• Benzodiazepine Receptor 50%
• Generalized Anxiety Disorder 50%
• 2-Deoxy-D-Glucose 50%
• Isoprenaline 50%
• Clorazepate 50%
• Receptor 50%
• Brain Region 50%

Medicine and Dentistry

• Positron Emission Tomography 100%
• Metabolic Rate 100%
• Patient with Anxiety Disorder 100%
• Benzodiazepine Derivative 100%
• Receptor Binding 33%
• Placebo 33%
• Visual Cortex 33%
• Thalamus 33%
• Receptor 33%
• Basal Ganglia 33%
• Brain Region 33%
• Fluorine-18 33%
• Isoprenaline 33%
• Deoxyglucose 33%
• Generalized Anxiety Disorder 33%
• Benzodiazepine Receptor 33%
• Clorazepate 33%